Cargando…

Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems

Nanotechnologies have attracted increasing attention in their application in medicine, especially in the development of new drug delivery systems. With the help of nano-sized carriers, drugs can reach specific diseased areas, prolonging therapeutic efficacy while decreasing undesired side-effects. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Su, Shi, M. Kang, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559885/
https://www.ncbi.nlm.nih.gov/pubmed/32882875
http://dx.doi.org/10.3390/pharmaceutics12090837
_version_ 1783594962693128192
author Su, Shi
M. Kang, Peter
author_facet Su, Shi
M. Kang, Peter
author_sort Su, Shi
collection PubMed
description Nanotechnologies have attracted increasing attention in their application in medicine, especially in the development of new drug delivery systems. With the help of nano-sized carriers, drugs can reach specific diseased areas, prolonging therapeutic efficacy while decreasing undesired side-effects. In addition, recent nanotechnological advances, such as surface stabilization and stimuli-responsive functionalization have also significantly improved the targeting capacity and therapeutic efficacy of the nanocarrier assisted drug delivery system. In this review, we evaluate recent advances in the development of different nanocarriers and their applications in therapeutics delivery.
format Online
Article
Text
id pubmed-7559885
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75598852020-10-22 Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems Su, Shi M. Kang, Peter Pharmaceutics Review Nanotechnologies have attracted increasing attention in their application in medicine, especially in the development of new drug delivery systems. With the help of nano-sized carriers, drugs can reach specific diseased areas, prolonging therapeutic efficacy while decreasing undesired side-effects. In addition, recent nanotechnological advances, such as surface stabilization and stimuli-responsive functionalization have also significantly improved the targeting capacity and therapeutic efficacy of the nanocarrier assisted drug delivery system. In this review, we evaluate recent advances in the development of different nanocarriers and their applications in therapeutics delivery. MDPI 2020-09-01 /pmc/articles/PMC7559885/ /pubmed/32882875 http://dx.doi.org/10.3390/pharmaceutics12090837 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Su, Shi
M. Kang, Peter
Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
title Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
title_full Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
title_fullStr Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
title_full_unstemmed Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
title_short Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
title_sort recent advances in nanocarrier-assisted therapeutics delivery systems
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559885/
https://www.ncbi.nlm.nih.gov/pubmed/32882875
http://dx.doi.org/10.3390/pharmaceutics12090837
work_keys_str_mv AT sushi recentadvancesinnanocarrierassistedtherapeuticsdeliverysystems
AT mkangpeter recentadvancesinnanocarrierassistedtherapeuticsdeliverysystems